Author:
Zhaohui Zhu,Shian Xing,Ping Cheng,Guosheng Li,Yu Yang,Fuqing Zeng,Gongcheng Lu
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Biomedical Engineering,Biomaterials,Biochemistry
Reference8 articles.
1. Onda H, Yasuda M, Serizawa Aet al. Clinical outcome in localized renal cell carcinomas related to immunoexpression of proliferating cell nuclear antigen, Ki-67 antigen, and tumor size. Oncol Rep, 1999, 6: 1039
2. Levine A J, Momad J, Finlay C Aet al. The p53 tumor supressor gene. Nature, 1991, 351: 453
3. Hofmockel G, Wittmann A, Dammrich Jet al. Expression of p53, bcl-2 in primary locally confined prognostic renal cell carcinoma: no evidence for prognostic significance. Anticancae Res, 1996, 16: 3807
4. Sejima T, Miyagama I. Expression of bcl-2, p53 oncoprotein and proliferating cell nuclear antigen in renal cell carcinoma. Eur Urol, 1999, 35: 242
5. Uchida T, Wada C, Schitara Tet al. Infrequent involvement of p53 mutation and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Urol, 1993, 150: 1298
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献